Prestige Consumer Healthcare Inc. (PBH): Share Repurchases
$156.28M
Year ended 2026-03-31
$121.51M
Trailing 12 months to 2026-06-30
+46.2%
3-year compound annual growth
+67.5%
5-year compound annual growth
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $156.28M | +203.4% | 2026-05-14, From 2025-04-01 |
| 2025-03-31 | $51.51M | +106.0% | 2026-05-14, From 2024-04-01 |
| 2024-03-31 | $25.00M | -50.0% | 2026-05-14, From 2023-04-01 |
| 2023-03-31 | $50.00M | n/a | 2025-05-09, From 2022-04-01 |
| 2022-03-31 | $0 | -100.0% | 2024-05-15, From 2021-04-01 |
| 2021-03-31 | $11.87M | -79.1% | 2023-05-05, From 2020-04-01 |
| 2020-03-31 | $56.72M | +13.5% | 2022-05-06, From 2019-04-01 |
| 2019-03-31 | $49.98M | n/a | 2021-05-07, From 2018-04-01 |
| 2018-03-31 | $0 | n/a | 2020-05-08, From 2017-04-01 |
| 2017-03-31 | $0 | n/a | 2019-05-13, From 2016-04-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $156.28M | +203.4% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $11.00M | -93.6% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $12.21M | +11.4% |
| Alkermes plc. (ALKS) | 2024-12-31 | $200.28M | n/a |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $25.10M | -58.2% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $172.91M | n/m |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $24.90M | n/a |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $148.33M | +493.3% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $75.59M | -11.6% |
Compare PBH, INDV, ANIP, ALKS side by side · Screen every company in Pharmaceutical Preparations ↗